Evaluating Urinary Biomarkers for Early Detection of Kidney Damage in Immune Checkpoint Inhibitors-Treated Patients
The proposed biomarker battery could be used as a preventive tool for decision-making in the management of oncology patients at risk for kidney damage associated with ICIs. Furthermore, its use would allow personalized adjustment of therapy that would minimize the probability of renal complications even before starting the first cycle of treatment.
Authors
- E. del Barco (ORCID: https://orcid.org/0000-0001-6443-0585)
- Moisés Pescador
- Laura Vicente-Vicente (ORCID: https://orcid.org/0000-0002-6273-4005)
- Milagros Hijas
- A. Olivares (ORCID: https://orcid.org/0000-0002-8541-8144)
- Marta Prieto (ORCID: https://orcid.org/0000-0002-2540-4461)
- Alfredo G. Casanova (ORCID: https://orcid.org/0000-0002-0725-6637)
- Teresa Carretero
- Javier Tascón (ORCID: https://orcid.org/0000-0002-8690-446X)
- Ana I. Morales (ORCID: https://orcid.org/0000-0001-6836-6138)
- Ana C Sánchez-Sierra
- Elena Villanueva-Sánchez
Institutions
- Universidad de Salamanca (ES)
- Complejo Hospitalario de Salamanca (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Hospital Clínico Universitario de Valladolid (ES)
Publication Details
- Journal
- American Journal of Nephrology
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1159/000548773
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Banco Santander
- European Commission
- Instituto de Salud Carlos III